Heartland Advisors Inc. Has $9.21 Million Stock Position in Teleflex Incorporated (NYSE:TFX)

Heartland Advisors Inc. increased its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 176.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 51,764 shares of the medical technology company's stock after buying an additional 33,018 shares during the period. Heartland Advisors Inc. owned about 0.11% of Teleflex worth $9,213,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the business. Cerity Partners LLC grew its stake in Teleflex by 49.3% during the 3rd quarter. Cerity Partners LLC now owns 13,374 shares of the medical technology company's stock worth $3,308,000 after buying an additional 4,415 shares during the last quarter. Daiwa Securities Group Inc. increased its holdings in shares of Teleflex by 10.9% in the 3rd quarter. Daiwa Securities Group Inc. now owns 11,295 shares of the medical technology company's stock worth $2,793,000 after acquiring an additional 1,106 shares during the period. FMR LLC lifted its position in Teleflex by 70.1% in the 3rd quarter. FMR LLC now owns 269,490 shares of the medical technology company's stock valued at $66,650,000 after purchasing an additional 111,086 shares during the last quarter. BNP Paribas Financial Markets boosted its stake in Teleflex by 14.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 64,498 shares of the medical technology company's stock valued at $15,952,000 after purchasing an additional 7,907 shares during the period. Finally, Townsquare Capital LLC bought a new stake in shares of Teleflex during the third quarter valued at approximately $200,000. Institutional investors own 95.62% of the company's stock.

Remove Ads

Teleflex Trading Up 1.4 %

Shares of NYSE TFX traded up $2.00 during mid-day trading on Tuesday, hitting $140.19. 307,206 shares of the company traded hands, compared to its average volume of 1,053,863. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1 year low of $128.55 and a 1 year high of $249.90. The stock has a market capitalization of $6.50 billion, a price-to-earnings ratio of 27.87, a PEG ratio of 1.73 and a beta of 1.21. The business has a 50 day moving average of $158.33 and a two-hundred day moving average of $189.25.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. On average, sell-side analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 0.97%. Teleflex's dividend payout ratio (DPR) is presently 95.77%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on TFX shares. Piper Sandler reissued a "neutral" rating and issued a $140.00 price objective (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. StockNews.com lowered Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. Truist Financial lowered their target price on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating on the stock in a research note on Monday, March 3rd. Finally, Bank of America cut shares of Teleflex from a "neutral" rating to an "underperform" rating and decreased their price objective for the company from $235.00 to $140.00 in a report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, Teleflex presently has an average rating of "Hold" and a consensus target price of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.